RxDoctor Payments Data

Andrea Turek

Medical · Chicago, ILNPI 1669754511

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $112,981 of the $145,301 with a category attached, or 77.8%. AbbVie accounts for 75.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $64,250 and has fallen 67.8% since, to $20,676 in 2025. Among medical clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$145,301in general payments, 2019–2025

Across 389 payments — averaging $373.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$109K
  • Galderma Laboratories, L.p.$23K
  • Merz North America, Inc.$13K
  • Revance Therapeutics, Inc.$143

What the payments were for

  • Speaking & faculty fees$112,98178%
  • Travel & lodging$20,72414%
  • Food & beverage$11,5028%
  • Education$940%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)260$109,014
Galderma Laboratories, L.p.58$22,892
Merz North America, Inc.70$13,252
Revance Therapeutics, Inc.1$143

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$145,301 in reported general payments places this provider in the 95th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois →

Other medical in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →